PL BioScience Welcomes Maik W. Jornitz to Board of Directors

PL BioScience GmbH, a German company specializing in Human Platelet Lysate (HPL) for cell expansion, announced Maik W. Jornitz's appointment to its board of directors. Jornitz brings nearly four decades of experience in biopharmaceutical processing to the role. His career includes senior leadership roles at Sartorius and G-CON Manufacturing Inc, giving him strategic insight as PL BioScience seeks global growth.

Jornitz is recognized for his work in sterilization, single-use bioprocesses, and aseptic processing. He has written several key publications and served as Board Chair of the Parenteral Drug Association. His expertise aligns with PL BioScience's vision to expand within cell therapy and clinical applications.

CEO Hatim Hemeda expressed enthusiasm about Jornitz's addition, citing his industry influence as an asset to their strategic goals. Jornitz looks forward to contributing to the company's growth and innovation in the biopharmaceutical sector.